Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Annals of Translational Medicine|April 21, 2023
The inhibitory effect of isoliquiritigenin on human platelets <i>in vitro</i>Yingying Wu, Cheng Deng, Yixuan Wang, et al.
Journal of Clinical and Translational Hepatology|August 14, 2023
Hepatitis Virus-associated Non-hodgkin Lymphoma: Pathogenesis and Treatment StrategiesWenjing Zhang, Fan Du, Li Wang, et al.
International Journal of Molecular Sciences|March 28, 2009
Inhibition of tissue factor expression in brain microvascular endothelial cells by nanoparticles loading NF-kappaB decoy oligonucleotidesHuafang Wang, Yu Hu, Tao Guo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2024
[<sup>18</sup>F]FDG PET/CT for prognosis and toxicity prediction of diffuse large B-cell lymphoma patients with chimeric antigen receptor T-cell therapyJinbo Gui, Mengting Li, Jia Xu, et al.
Med (New York, N.Y.)|April 12, 2024
The enchanting canvas of CAR technology: Unveiling its wonders in non-neoplastic diseasesJinhui Shu, Wei Xie, Zhaozhao Chen, et al.
Materials Today. Bio|April 17, 2023
TGF-β blocking combined with photothermal therapy promote tumor targeted migration and long-term antitumor activity of CAR-T cellsYuxiang Tang, WeiQi Yao, Hang Hu, et al.
Acta Biochimica Et Biophysica Sinica|June 9, 2006
Immunogenicity of C-terminus of Plasmodium falciparum merozoite surface protein 1 expressed as a non-glycosylated polypeptide in yeastZhong-Guang Zhang, Wen-Gang Yu, Wen-Sheng Qiu, et al.
Life Sciences|November 11, 2017
CRISPR-mediated deletion of the PECAM-1 cytoplasmic domain increases receptor lateral mobility and strengthens endothelial cell junctional integrityDanying Liao, Heng Mei, Yu Hu, et al.
Bioactive Materials|September 20, 2021
Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modificationHeng Mei, Shengsheng Cai, Dennis Huang, et al.
Blood Cancer Journal|July 14, 2026
Subsequent CAR-T and engineered antibody for relapsed/refractory multiple myeloma following BCMA-targeted treatment: a systematic review and meta-analysisYun Kang, Qiaolin Liu, Lin Liu, et al.
Pageof 19